These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 2548744)

  • 1. [Observation of live, attenuated hepatitis A vaccines in humans].
    Hu MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):65-8. PubMed ID: 8394801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trial preparation of attenuated live hepatitis A vaccine.
    Dong DX; Lian YH; Chen TQ; Li J; Liang WS; Cao YY; Mao JS; Chen NL; Chai SA; Huang HY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(4):199-202. PubMed ID: 2854634
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological effects of live attenuated hepatitis A vaccine].
    Cheng NL
    Zhonghua Yi Xue Za Zhi; 1992 Oct; 72(10):581-3, 638. PubMed ID: 1338501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditable characteristics of attenuated live hepatitis A virus H2 strain].
    Chai SA
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):335-7, 380. PubMed ID: 8258101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The trial preparation of attenuated live hepatitis A vaccine].
    Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):1-6. PubMed ID: 2548744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral hepatitis and immunoprophylaxis].
    Deinhardt F; Jilg W
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):134-45. PubMed ID: 2986380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of viral hepatitis A: past, present and future.
    Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S10-4. PubMed ID: 1335635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the control of hepatitis A by vaccination.
    Kane MA
    Vaccine; 1992; 10 Suppl 1():S93-6. PubMed ID: 1335670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible approaches to develop vaccines against hepatitis A.
    D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for a hepatitis A virus vaccine.
    Flehmig B; Heinricy U; Pfisterer M
    Prog Med Virol; 1990; 37():56-71. PubMed ID: 2173849
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.